BD to Present at Investor Healthcare Conferences

FRANKLIN LAKES, N.J., Nov. 4 /PRNewswire-FirstCall/ -- BD (Becton, Dickinson
and Company) (NYSE: BDX), a global medical technology company, announced today
that it would present at the following investor healthcare conferences:

2009 Annual Credit Suisse Healthcare Conference
November 11, 2009
11:00 a.m. EST

Piper Jaffray 21st Annual Healthcare Conference
December 2, 2009
1:00 p.m. EST

A live webcast of BD's presentations can be accessed from the BD corporate
website at www.bd.com/investors. They will be available for replay for a
period of seven days.

BD is a leading global medical technology company that develops, manufactures
and sells medical devices, instrument systems and reagents. The Company is
dedicated to improving people's health throughout the world. BD is focused on
improving drug delivery, enhancing the quality and speed of diagnosing
infectious diseases and cancers, and advancing research, discovery and
production of new drugs and vaccines. BD's capabilities are instrumental in
combating many of the world's most pressing diseases. Founded in 1897 and
headquartered in Franklin Lakes, New Jersey, BD employs approximately 29,000
associates in approximately 50 countries throughout the world. The Company
serves healthcare institutions, life science researchers, clinical
laboratories, the pharmaceutical industry and the general public. For more
information, please visit www.bd.com.

SOURCE BD (Becton, Dickinson and Company)

Patricia A. Spinella, Investor Relations, +1-201-847-5453, or Colleen T.
White, Corporate Communications, +1-201-847-5369